Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2014-09-11 Legal Proceedings Report
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Biotage framgång i omprövningsförfarande
Legal Proceedings Report Classification · 99% confidence The document is a press release dated September 11, 2014, announcing a significant legal victory for Biotage AB. Specifically, it details that the U.S. Court of Appeals for the Federal Circuit invalidated all patent claims in three US patents (7,138,061, 7,381,327, and 7,410,571) following a patent infringement lawsuit initiated by Scientific Plastic Products, Inc. This content directly relates to significant lawsuits and regulatory/legal matters involving the company. Therefore, it fits the definition of a Legal Proceedings Report (LTR). It is not a general earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it concerns a specific legal outcome.
2014-09-11 Swedish
Biotage success in re-examination proceedings
Legal Proceedings Report Classification · 98% confidence The document is a press release from Biotage AB dated September 11, 2014, announcing the outcome of a legal/patent dispute where the U.S. Court of Appeals for the Federal Circuit affirmed the rejection of patent claims against Scientific Plastic Products, Inc. This content relates to significant legal matters involving the company. Based on the definitions, the category 'Legal Proceedings Report (Code: LTR)' is the most appropriate fit, as it covers updates on significant lawsuits or regulatory actions. The document is a direct announcement of a legal resolution, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains substantive information about the legal outcome.
2014-09-11 English
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport för perioden januari - juni 2014' (Interim report for the period January - June 2014). It contains comprehensive financial statements, including income statements, balance sheet summaries, cash flow analysis, and management commentary on business performance for the second quarter and the first half of 2014. It is a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report. H1 2014
2014-08-14 Swedish
Interim / Quarterly Report 2014
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report for the period January – June 2014' and contains comprehensive financial statements, including income statements, balance sheet items, cash flow analysis, and management commentary for the specified period. It is clearly a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2014
2014-08-14 English
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 98% confidence The document details a change in shareholding ('Holder: Varenne AB') for the issuer Biotage AB, specifically reporting the 'Resulting distribution of total holdings' and the 'Percentage of voting rights' before and after a transaction on 30/04/2014. The structure, focusing on shares, voting rights, and thresholds (5%), is characteristic of a notification regarding a change in significant share ownership. This aligns directly with the definition for Major Shareholding Notification (MRQ). The document is short and appears to be the notification itself, not an announcement of a report.
2014-05-05 English
Biotage AB – förändring i antal aktier och röster
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a press release from Biotage AB dated April 30, 2014. The core content announces a change in the number of outstanding shares following the cancellation (buyback/withdrawal) of 5,146,883 shares decided at the Annual General Meeting (AGM) on April 28, 2014. This action directly relates to the company's capital structure and share count. This fits the definition of 'Share Issue/Capital Change' (SHA), which covers changes to the capital structure, including share cancellations resulting from buybacks. Although it mentions the AGM, the primary focus is the resulting share count change, not the AGM materials (AGM-R) or the buyback transaction itself (POS, which is usually the execution of the buyback, not the resulting count change announcement). Since it is a direct announcement of a capital structure change, SHA is the most appropriate code.
2014-04-30 Swedish

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.